Home
Conditions
Treatments
Trials
Explore
🏠
/
treatments
/
MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)
/
mega-study
MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)